Trends Parasitol by Johansson, Michael A.
Chikungunya on the move
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Abstract
In December 2013, chikungunya virus (CHIKV) transmission was reported for the first time in the 
Americas. Since then it has spread quickly, with more than 1 million suspected and confirmed 
cases being reported in one year, where previously there were only sporadic travel-related cases. 
Transmission patterns suggest that the epidemic in the southern hemisphere is only beginning and 
that chikungunya will not go away anytime soon.
In the early 1950s an acute disease marked by fever, joint pain, and rash was affecting the 
residents of the Makonde Plateau region of Tanzania [1]. Known as chikungunya for the 
way the joint pain ‘bent’ people, the disease manifested in intense outbreaks affecting 60–
80% of people in small villages. Recognizing that spread of this disease was similar to that 
noted in dengue outbreaks, Ronald Ross isolated a previously unknown alphavirus, CHIKV 
[2].
CHIKV is transmitted between humans by Aedes aegypti and Ae. albopictus mosquitoes 
which are common throughout the tropical and subtropical regions of the world and that are 
also responsible for the transmission of the more widespread dengue viruses. The outbreak 
in Tanzania was not the first or last outbreak of chikungunya. Intense but sporadic outbreaks 
occurred in Africa and Asia throughout the latter half of the 20th century. In 2004, a large 
outbreak in Kenya spilled into the islands of the Indian Ocean and Asia leading to a multi-
year pandemic with more than a million cases [3]. This outbreak and increased activity in 
South-East Asia [4,5] marked a change in the global landscape of CHIKV as transmission 
became much more widespread.
With more infections occurring in more locations it also became more likely that travelers 
would enable international spread of the virus. In the summer of 2007 an infected traveler 
introduced CHIKV into Italy. With local mosquitoes and warm temperatures supportive of 
CHIKV transmission, this introduction led to the first European outbreak of chikungunya, 
with at least 205 people being infected [6]. In the Americas, where dengue is widespread 
and infected travelers were also arriving, local transmission had yet to occur [7].
In December 2013, a local CHIKV infection was confirmed on St. Martin in the Caribbean. 
Within weeks this was followed by confirmed cases in other nearby islands (Figure 1). A 
total of 111 cases were reported in December, which rapidly increased to 2487 in January 
and roughly doubled in the following months (Figure 2) (http://www.paho.org/
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chikungunya). As the number of cases increased, chikungunya also expanded 
geographically. By late February, local CHIKV transmission had been reported from ten 
locations: St. Martin, St. Barthelemy, Martinique, Guadeloupe, St. Maarten, the British 
Virgin Islands, Dominica, Anguilla, French Guiana, and St. Kitts and Nevis. In April, three 
new locations reported local cases, followed by four more in May, five in June, nine in July, 
two in August, three in September, three in October, three in November, and one in 
December. As of December 12, 2014, 43 countries and territories in the Americas had 
reported autochthonous CHIKV transmission for the first time in 2013–2014. A total of 
more than 1 million suspected and confirmed chikungunya cases had been reported in areas 
where only sporadic travel-associated cases had previously been reported.
Several patterns in the epidemic are evident. First, human movement has been crucial for the 
international spread of CHIKV. Early CHIKV isolates from St. Martin indicated that the 
virus was the Asian genotype, with a closely related isolate from the Philippines also in 
2013 [8]. Exactly how the virus arrived will likely never be known, but clearly one or more 
infected travelers enabled it to move halfway around the world within a matter of months. 
Spread within the American continents was also extremely rapid. Models highlight how 
human mobility at small and large scales contributes to the speed of spread [9,10]. As with 
previous outbreaks in the Indian Ocean epidemic, it is increasingly evident that globalization 
facilitates movement of pathogens at unprecedented speed.
Second, the incidence of chikungunya is following seasonal patterns. Martinique and 
Guadeloupe first reported local chikungunya cases in December, but incidence did not peak 
until July (Figure 2). Meanwhile, in the Dominican Republic, where cases were first 
reported in April, the peak also occurred in July. While CHIKV was introduced at different 
times across the Caribbean, a seasonal pattern is apparent across the region. This seasonality 
is very similar to dengue; hot and wet conditions favor the transmission of mosquito-borne 
viruses. The first chikungunya cases occurred during the relatively cool and dry winter 
months when dengue cases are also generally low, but transmission across the region took 
off with the warmer and wetter summer weather. This pattern is also evident in the southern 
hemisphere where the peak dengue season is reversed. Despite the previous arrival of 
infected travelers, no local chikungunya cases were reported until September. Unfortunately, 
this portends increased chikungunya in these regions in the coming months because CHIKV 
is now present and the dengue season is beginning.
Third, similarly to chikungunya epidemics in other areas with little pre-existing immunity, 
transmission has been intense. In the current epidemic the number of cases reported by 
surveillance systems has already topped 10% of the population in several locations. 
However, the true incidence of infection is certainly several times higher. In a large outbreak 
in La Réunion, for example, there were an estimated 67 symptomatic chikungunya cases for 
each case reported by the surveillance system [11]. Retrospective investigations of other 
CHIKV outbreaks in naïve populations have shown attack rates on the order of 30–75% 
[12–14].
Together, these patterns portend a public health problem that is only beginning. 
Approximately 500 million people live in areas of the Americas where dengue is endemic. 
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Incidence in some locations, such as El Salvador, increased later in the year than in others, 
and numerous large dengue-endemic countries such as Brazil, Mexico, Peru, Ecuador, and 
Bolivia have so far reported limited local transmission if any (as of December 12, 2014). If 
historic attack rates of 30–75% are any indication, there could be several hundred million 
infections in the region within the first year or two of introduction. The number of cases 
reported will be much lower; a proportion of infections are asymptomatic and, as noted 
above, many symptomatic cases are not reported. Nonetheless, hospital emergency 
departments throughout the Americas are likely to be filled with chikungunya patients. 
While chikungunya has very low mortality, the morbidity is substantial, and some patients 
may experience persistent and potentially debilitating joint pain for months after the initial 
illness [3].
The impact of chikungunya on human health has vastly increased over the past two decades. 
Chikungunya presents challenges to nearly all aspects of public health: CHIKV has shown 
an ability to evolve, increasing its transmissibility [15]; clinical diagnosis and management 
of cases is complicated by co-circulation with dengue viruses and other pathogens that cause 
similar disease [3], and effective large-scale interventions (e.g., vaccines, vector control) are 
not available [3]. Ongoing research aims to improve diagnostics, clinical management, and 
prevention tools including therapeutics, vaccines, personal protection measures, and vector 
control.
At the same time, it will be essential to establish surveillance systems to monitor 
chikungunya activity in the Americas. It is possible that CHIKV will become endemic in the 
Americas. High attack rates lead to herd immunity at the population level, making future 
outbreaks less likely. However, the heterogeneous landscape of that immunity will still leave 
many locations susceptible to outbreaks, and human movement throughout the region, 
especially linking northern, southern, and tropical climates, will facilitate reintroduction. 
Chikungunya is likely here to stay.
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Figure 1. 
The geographical pattern of chikungunya spread in the Americas by month of first reported 
autochthonous case.
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Figure 2. 
Chikungunya cases reported by month. Red bars indicate the number of cases reported each 
month including suspected and confirmed, imported and autochthonous cases. Orange bars 
indicate the cumulative number of countries or territories reporting autochthonous cases. 
Data were compiled from Pan American Health Organization reports (http://www.paho.org/
chikungunya) using cumulative reports published closest to the end of each month. *The US 
includes cases in Puerto Rico and the US Virgin Islands where large outbreaks are ongoing.
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